Rtw Investments, LP Acadia Pharmaceuticals Inc Transaction History
Rtw Investments, LP
- $6.13 Billion
- Q4 2024
A detailed history of Rtw Investments, LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Rtw Investments, LP holds 8,705,501 shares of ACAD stock, worth $149 Million. This represents 2.61% of its overall portfolio holdings.
Number of Shares
8,705,501
Previous 13,707,506
36.49%
Holding current value
$149 Million
Previous $211 Million
24.28%
% of portfolio
2.61%
Previous 3.36%
Shares
9 transactions
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$732 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$238 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$206 Million0.0% of portfolio
-
Morgan Stanley New York, NY7.3MShares$125 Million0.01% of portfolio
-
State Street Corp Boston, MA4.52MShares$77.2 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.76B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...